JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) Trading Down 0.2% – Here’s What Happened

Shares of JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) traded down 0.2% on Friday . The stock traded as low as $57.57 and last traded at $57.57. 805 shares were traded during trading, a decline of 10% from the average session volume of 895 shares. The stock had previously closed at $57.67.

JPMorgan Healthcare Leaders ETF Stock Down 0.2%

The company’s fifty day moving average is $56.01 and its two-hundred day moving average is $57.20. The stock has a market cap of $11.51 million, a price-to-earnings ratio of 22.43 and a beta of 0.44.

Hedge Funds Weigh In On JPMorgan Healthcare Leaders ETF

Institutional investors and hedge funds have recently bought and sold shares of the stock. Jane Street Group LLC acquired a new position in shares of JPMorgan Healthcare Leaders ETF in the 2nd quarter valued at approximately $1,166,000. Krilogy Financial LLC acquired a new position in shares of JPMorgan Healthcare Leaders ETF in the 3rd quarter valued at $325,000. Ignite Planners LLC lifted its stake in JPMorgan Healthcare Leaders ETF by 136.8% in the 4th quarter. Ignite Planners LLC now owns 9,460 shares of the company’s stock worth $553,000 after acquiring an additional 5,465 shares in the last quarter. Blue Water Asset Management purchased a new stake in shares of JPMorgan Healthcare Leaders ETF during the 4th quarter worth about $237,000. Finally, Sanctuary Advisors LLC increased its holdings in shares of JPMorgan Healthcare Leaders ETF by 12.7% during the 4th quarter. Sanctuary Advisors LLC now owns 6,359 shares of the company’s stock valued at $368,000 after acquiring an additional 718 shares during the last quarter.

JPMorgan Healthcare Leaders ETF Company Profile

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.